Can AI shrink the billions we spend developing drugs? BioPhy thinks so. It says it knows how to do it.

from blog Crazy Stupid Tech, | ↗ original
By Fred Vogelstein Every new drug that goes into development is a multi year, multi billion dollar gamble. Those that make it to approval - through the five to ten year gauntlet of clinical trials and regulatory scrutiny - grant their creators a license to print money for nearly a decade. The problem is that only about one in ten make it that...